Key terms
About BTMD
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company is headquartered in Irving, TX.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BTMD news
May 07
4:50pm ET
Biote affirms FY24 revenue view of $200M-$204M, consensus $202.3M
May 07
4:49pm ET
Biote reports Q1 EPS (6c), consensus 3c
Apr 29
4:32pm ET
Biote Settles Litigation and Repurchases Shares from Founder
Apr 29
4:19pm ET
Biote enters into settlement with founder Gary Donovitz
Apr 04
4:55am ET
Biote management to meet with B. Riley
Mar 28
3:44pm ET
Biote management to meet with B. Riley
Mar 14
9:15pm ET
Optimistic Outlook: Biote’s Growth Potential and Strategic Initiatives Despite Transitional Challenges
Mar 14
4:24pm ET
Biote Corp. Releases March 2024 Investor Presentation
Mar 13
7:49am ET
Biote price target raised to $9 from $8 at Roth MKM
Mar 13
7:40am ET
Analysts Are Bullish on Top Healthcare Stocks: biote (BTMD), Incyte (INCY)
Mar 12
4:09pm ET
Biote sees FY24 revenue $200M-$204M, consensus $203.17M
Mar 12
4:08pm ET
Biote reports Q4 EPS 18c, consensus 8c
Feb 27
7:48am ET
Truist Financial Issues a Buy Rating on biote (BTMD)
Feb 20
9:15pm ET
Buy Rating on Biote’s Stock: A Positive Outlook Amidst Nutraceutical Challenges
Feb 20
4:35pm ET
Biote Corp. Settles Litigation and Repurchases Founder’s Shares
Feb 20
8:50am ET
B. Riley starts Biote with Buy on horome replacement therapy potential
Feb 20
8:50am ET
B. Riley starts Biote with Buy on horome replacement therapy potential
Feb 20
5:41am ET
Biote initiated with a Buy at B. Riley
No recent press releases are available for BTMD
BTMD Financials
Key terms
Ad Feedback
BTMD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BTMD Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range